🟢 Korro Bio, Inc. is trading 10.36% up today after Jones Trading upgrade and positive RNA editing data

Korro Bio, Inc. is trading at $12.20 (+10.36%) today following a Jones Trading upgrade to Buy and reports of promising preclinical RNA editing data.

• Jones Trading set a new price target of $23.00, while H.C. Wainwright maintained its Buy rating with a $15.00 target.
• The stock's upward momentum is driven by encouraging results from the company's RNA editing platform, which sparked a significant pre-market rally.